New search | Conferencedetail
Print view
 
 

Complement-based Drug Development Summit

evvnt Platform / evvnt
-
13.11.2018 - 15.11.2018  Hilton Boston Logan Airport, 1 Hotel Drive, 02128 Boston, USA
Time: 08:00 to 17:00
 
Conference themes
"Optimize complex discovery, biomarker validation and clinical translation to develop complement inhibition for rare and common diseases"

With the only approved complement therapeutic, Soliris, on the market for over a decade, the industry is overflowing with companies in clinical translation in a race for the next approval.
Professional congress organizer (PCO)
Hanson Wade
Notes
Brochure: https://go.evvnt.com/257815-0?pid=4832

Speakers: Mark Ma, Senior Director, Bioanalytical and Biomarker Development, Alexion Research, Mingjun Huang, Senior Vice President and Head of Research, Achillion Pharmaceuticals, and more.
 

Enquiries and Registration:

https://go.evvnt.com/257815-3?pid=4832
Ms. Paulina Szymanska
 
Categories
General Medicine
Languages
English
Congress fees
Conference + 2 Workshops (A and B): USD 3299.0, Conference + 1 Workshop (A or B): USD 2799.0, Conference Only: USD 2299.0, Workshops (Individual): USD 699.0
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Helix - Forschung & Beratung WienCharité International AcademyAGEM - Arbeitsgemeinschaft Ethnomedizin e. V.European Public Health Association (EUPHA)Ärztekammer für WienÖsterreichische Gesellschaft für Public HealthAnästhesie in Entwicklungsländern e. V.Ärzte der Welt

Facebook

Give us your professional opinion

Start survey

Start survey